Abrupt Ban On Pioglitazone Angers Industry, Medical Experts; Is A Rollback In The Cards?
This article was originally published in PharmAsia News
Executive Summary
Major players in the Indian drug industry expressed disappointment on the unilateral decision of the health ministry to ban pioglitazone and its combinations.